← All trials
NCT03275558
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 17, 2018
- Primary completion
- Jul 17, 2018
- Completion date
- Jul 17, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- —
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Center Trials & Treatment Inc.Lead sponsor
- Center Trials & Treatment Inc.Overall official - principal investigator
- Center Trials & Treatment Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.